Subgroup Analysis of Patients with Cancer in XALIA: A Noninterventional Study of Rivaroxaban versus Standard Anticoagulation for VTE

Eitemau Tebyg

• Patient-Reported Treatment Experience with Oral Rivaroxaban: Results from the Noninterventional XALIA Study of Deep-Vein Thrombosis
  gan: Stefan Cano, et al.
  Cyhoeddwyd: (2018-04-01)
• Anticoagulant treatment for venous thromboembolism: A pooled analysis and additional results of the XALIA and XALIA‐LEA noninterventional studies
  gan: Sylvia Haas, et al.
  Cyhoeddwyd: (2021-03-01)
• Patient Management Strategies and Long-Term Outcomes in Isolated Distal Deep-Vein Thrombosis versus Proximal Deep-Vein Thrombosis: Findings from XALIA
  gan: Walter Ageno, et al.
  Cyhoeddwyd: (2019-01-01)
• Characteristics and Effect of Rivaroxaban on Venous Thromboembolism in Korean Patients Compared to Western Population: A Subgroup Analysis from XALIA(-LEA) Study
  gan: Seung-Kee Min, et al.
  Cyhoeddwyd: (2022-12-01)
• A review of pharmacogenetics of anticoagulant therapy: Heparins, rivaroxaban, apixaban, and dabigatran
  gan: Ali Mohammed Abd Alridha, et al.
  Cyhoeddwyd: (2022-01-01)